ARTICLE | Finance
IPO watch
Israel's Aposense floats IPO; gets more funding from Teva
June 14, 2010 7:00 AM UTC
Israeli molecular imaging and apoptosis play Aposense Ltd. (Tel Aviv:APOS) raised NIS95.9 million ($24.8 million) through the sale of 3 million shares at NIS31.50 in an IPO on the Tel Aviv Stock Exchange and concurrent private placements.
The price values the company at NIS834.9 million ($215.7 million)...